Monograph Details
|
|
Cardiovascular System
> Angina
|
|
PROCARDIA XL |
| Manufacturer |
|
Pfizer Labs |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Calcium channel blocker (dihydropyridine). |
| Generic Name |
|
Nifedipine 30mg, 60mg, 90mg; ext-rel tabs. |
| Indications |
|
Vasospastic and chronic stable angina. |
| Children |
|
Not recommended. |
| Adults |
|
Swallow whole. Initially 30–60mg once daily, titrate over 7–14 days; usual max 90mg/day. |
| Precautions |
|
Aortic stenosis. Severe obstructive coronary artery disease. Heart failure. GI narrowing (tabs). Monitor blood pressure initially and during titration. Avoid abrupt cessation. Pregnancy (Cat.C). Nursing mothers: not recommended. |
| Interactions |
|
Hypotension, angina, and heart failure possible with β-blockers. Potentiated by cimetidine, grapefruit juice. Potentiates antihypertensives, digoxin. Hypotension possible with fentanyl. Monitor oral anticoagulants, quinidine. |
| Adverse Reactions |
|
Edema, headache, fatigue, dizziness, constipation, nausea, palpitations, muscle cramps; rare: increased angina, acute MI. |
| How Supplied |
Tabs 30mg, 60mg—100, 300
Tabs 90mg—100
Caps 10mg—100, 300
Caps 20mg—100 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
